Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Expression Profile of Primary Colorectal Cancers and associated Liver Metastases

ABSTRACT: Comparison of expression profiles of primary colorectal cancers with liver metastases of the same patient. Additionally, expression data of normal colon and liver tissue. Abstract of publication will be included upon publication Keywords: expression profiling, colorectal cancer, colon cancer, liver metastasis, normal colonic tissue, normal liver tissue

ORGANISM(S): Homo sapiens

PROVIDER: GSE14297 | GEO | 2010/07/07

SECONDARY ACCESSION(S): PRJNA111295

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

Expression Profile of Primary Colorectal Cancers and associated Liver Metastases

Project description:Comparison of expression profiles of primary colorectal cancers with liver metastases of the same patient. Additionally, expression data of normal colon and liver tissue. Abstract of publication will be included upon publication Keywords: expression profiling, colorectal cancer, colon cancer, liver metastasis, normal colonic tissue, normal liver tissue RNA of 18 primary colorectal cancers, 18 matched liver metastases, 7 normal colon epithelium samples and 5 normal liver tissue samples hybridized on Human Sentrix-6 V2 (Illumina)

2010-07-07 | E-GEOD-14297 | biostudies-arrayexpress

E-GEOD-50760

Project description:RNA-seq of 54 samples (normal colon, primary tumor, and liver metastases) from 18 colorectal cancer patients

2025-01-24 | E-GEOD-50760 | ExpressionAtlas

Sequencing of DNA captured with a methyl-CpG binding domain (MBD) of primary colorectal cancers, with paired normal tissue, and liver metastases from different patients.

Project description:We sought to understand the mechanisms of cancer dissemination and to improve treatments for late-stage cancer patients. Laser tissue microdissection of 10 to 25 x 106 µm2 epithelium from sections of freshly-frozen colorectal cancers (no=6), colorectal cancer liver metastases (no=12) and normal colonic mucosa (no=3) was performed to extract DNA. Methylated DNA was captured using a methylCpG binding domain (MBD) polypeptide and deep sequenced. We detected hyper and hypomethylation in both colorectal cancers and metastases compared to normal tissue.

2020-01-03 | E-MTAB-8232 | biostudies-arrayexpress

Genomic Profile of Primary Colorectal Cancers and associated Liver Metastases

2010-07-07 | GSE10179 | GEO

Genomic Profile of Primary Colorectal Cancers and associated Liver Metastases

Project description:Comparison of genomic alterations of primary colorectal cancers with liver metastases of the same patient Keywords: array CGH, colorectal cancer, colon cancer, liver metastasis 21 primary colorectal cancers and 21 matched liver metastases hybridized against sex-matched control pools

2010-07-07 | E-GEOD-10179 | biostudies-arrayexpress

Comparing miRNA Signature of Colon Cancer Primary Tumors to Metastases Formed in the Liver

Project description:Genome wide miRNA expression profiling was performed using Affymetric miRNA v. 3.0 Array on 48 samples which included paired FFPE colon tuomor and metastisized liver and paired normal colon, normal liver). The data set was divided into two categories and identified by tissue source and patient demographics: Tissue (Colon, Liver), Source (Colon Tumor Liver Met, Colon Normal, Liver Normal), Sex (Male, Female), Patient Pair. microRNAs (miRs) are frequently dysregulated in colorectal cancer (CRC) and subsets are correlated with advanced tumor stage and metastasis. Despite this, the development of prognostic biomarkers that predict metastatic potential remain limited. Our study was designed to identify, validate, and elucidate underlying biology imposed by a miR signature that defines and predicts metastatic disease. Genome-wide miR expression profiling was performed on fourteen patient-matched stage IV primary CRC tumors and corresponding liver metastases using microRNA array technology. Based on these results, this miR panel was then validated and evaluated in normal colon tissue (N = 5), early stage (I & II, N = 11) and late stage (Stage III & IV, N = 14) colorectal primary tumors via qRT-PCR.

2017-05-02 | GSE98406 | GEO

E-GEOD-95132

Project description:RNA-seq of colorectal cancer primary tumor and adjacent colon tissue

2019-05-14 | E-GEOD-95132 | ExpressionAtlas

E-GEOD-51108

Project description:Gene expression in liver tissue from Ghrh-KO and normal (wild-type) mice

2015-07-27 | E-GEOD-51108 | ExpressionAtlas

Specific extracellular matrix remodeling signature of colon hepatic metastases

Project description:To identify genes implicated in metastatic colonization of the liver in colorectal cancer, we collected pairs of primary tumors and hepatic metastases before chemotherapy in 13 patients. We compared mRNA expression in the pairs of patients to identify genes deregulated during metastatic evolution. We then validated the identified genes using data obtained by different groups. The 33-gene signature was able to classify 87% of hepatic metastases, 98% of primary tumors, 97% of normal colon mucosa, and 95% of normal liver tissues in six datasets obtained using five different microarray platforms. The identified genes are specific to colon cancer and hepatic metastases since other metastatic locations and hepatic metastases originating from breast cancer were not classified by the signature. Gene Ontology term analysis showed that 50% of the genes are implicated in extracellular matrix remodeling, and more precisely in cell adhesion, extracellular matrix organization and angiogenesis. Because of the high efficiency of the signature to classify colon hepatic metastases, the identified genes represent promising targets to develop new therapies that will specifically affect hepatic metastasis microenvironment. 57 samples of patients with stage IV colorectal cancer. We compared using Affymetrix chips gene expression profiles between primary tumors and hepatic metastases

2013-09-01 | E-GEOD-49355 | biostudies-arrayexpress

Clariom S Microarray Expression Data from Mouse Colonic Lesion and Healthy Tissue following AOM/DSS Chemical Induction of Colitis-associated Colorectal Cancer to Assess NF-κB Mediated Intestinal Epithelial Cell Regeneration

Project description:This study sought to evaluate the diffferential gene expression following the conditional knockout of either the canonical (p65) or non-canonical (NIK) NF-κB signaling pathway in myeloid (LysMCre) or intestinal epithelial (VillinCre) cell deletions in a murine model. Genetic susceptibility to colitis-associated colorectal cancer via the chemical induction of AOM/DSS was evaluated on colonic lesion (LT) and healthy tissue (HT) using microarray to assess implicated genes/pathways downstream of NF-kappaB. Abstract from associated publication: Dysregulation of intestinal epithelial cell proliferation is a critical feature in the development of colorectal cancer. This malignancy is typically driven by loss of stem cell regulation in the crypts. Here, we show that NF-κB-inducing kinase (NIK) attenuates colorectal cancer through the regulation of intestinal epithelial cell regeneration and differentiation mediated by noncanonical NF-κB signaling. We observed increased tumor burden in mice lacking NIK either systemically or specifically in intestinal epithelial cells in a model of inflammation-induced tumorigenesis in the colon. Mechanistic studies using crypts and organoids revealed that loss of NIK results in the accumulation of mature, non-dividing colonic epithelial cells, which are more susceptible to mutations and eventual transformation. These findings are consistent with our observations in human colorectal cancer patients revealing a significant decrease in NIK and noncanonical NF-κB signaling. Our work extends previous findings for NIK in attenuating sepsis and gastrointestinal inflammation and defines a critical role for this kinase in colorectal cancer.

2023-04-23 | GSE227993 | GEO

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data